NMPA Approval

Gemcitabine Hydrochloride for Injection

Approval Number

国药准字H20123340

Registration Date

September 18, 2022

Previous Approval Numbers

国药准字H20123340

Drug Information

Generic Name

注射用盐酸吉西他滨

Dosage Form

注射剂

Strength

1.0g(以C9H11F2N3O4计)

Drug Type

化学药品

Registration Date

September 18, 2022

Company Address

山东省临沂高新技术产业开发区罗七路

Company Address

山东省临沂高新技术产业开发区罗七路

Empowering clinical research with data-driven insights and AI-powered tools.

注射用盐酸吉西他滨 - NMPA 批准文号 | MedPath